Ventilator-Associated Pneumonia (VAP)
Mechanically ventilated patients are at high risk for complications. These risks include VAP, peptic ulcer disease (PUD), gastrointestinal bleeding, aspiration, venous thromboembolic events (VTE), and problems with secretion management. Evidence-based interventions can reduce the risk of these complications and reduce the occurrence of VAP. Implementing the ventilator bundle has shown to reduce VAP. The VAP prevention bundle includes: head of bed elevated 30 to 45 degrees, oral care with chlorhexidine 0.12%, peptic ulcer prophylaxis, deep vein thrombosis prophylaxis, and spontaneous waking trials and spontaneous breathing trials.